Harpoon Therapeutics, Inc. (HARP) Stock: A Biotech Stock That’s Climbing


Harpoon Therapeutics, Inc. (HARP) is working its way for to the top in the market today. The stock, focused on the biotechnology sector, is presently trading at $12.55 after a move up of 8.00% so far today. As it relates to biotechnology stocks, there are several aspects that have the ability to generate price movement in the market. News is one of the most common reasons for movement. Here are the most recent stories associated with HARP:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-14-19 04:05PM Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar-13-19 04:07PM Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
Mar-07-19 04:05PM Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
10:11AM Shockwave Medical soars 79% after upsized IPO scores $97M
Mar-05-19 11:40AM Harpoon Therapeutics’ Platform To Drive Significant Value, Wedbush Says In Bullish Initiation

Nonetheless, any time investors are making an investing decision, investors should focus on much more than news, especially in the generally speculative biotechnology space. Here’s what’s happening in regard to Harpoon Therapeutics, Inc..

Recent Moves From HARP

Although a move up on a single session, like the gain that we’re seeing from Harpoon Therapeutics, Inc. may lead to excitement in some investors, a single session move alone should not be the reason for a decision to, or not to, invest in a stock. It is generally important to take a look at trends further out than a single session. In the case of HARP, below are the returns that investors have seen:

  • Past 5 Trading Sessions – Over the past 7 days, HARP has generated a price change amounting to -8.93%.
  • Past Month – The monthly performance from Harpoon Therapeutics, Inc. works out to -18.11%.
  • Quarterly – In the last three months, the company has produced a return on investment that works out to 0
  • Bi-Annually – In the past six months, we have seen a change that works out to 0 from the stock.
  • Year To Date – Since the open of this year HARP has produced a return of -13.93%.
  • Full Year – Finally, in the past year, we’ve seen performance that works out to 0 from HARP. Throughout this period, the stock has traded at a high price of -29.69% and a low of 19.18%.

Ratios Worth Watching

Digging into various ratios having to do with a stock generally gives investors a look of how dangerous and/or rewarding a stock pick may be. Below are some of the key ratios to look at when digging into HARP.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the price of the stock is headed for declines. Across the sector, biotechnology stocks can carry a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the space. Nonetheless, as it relates to Harpoon Therapeutics, Inc., it’s short ratio clocks in at 0.32.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Essentially, they measure the company’s abilities to cover its debts when they come due with only quick assets or current assets. In the biotech industry, many companies are reliant on the continuation of support from investors, the current and quick ratios can seem upsetting. However, quite a few good picks in the biotech space do have great quick and current ratios. As far as HARP, the quick and current ratios come to 3.80 and 3.80 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets that are owned by the company. In this particular case, the book to share value ratio comes in at -1.37.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the price of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotech space, this is an important ratio to think about. As it relates to HARP, the cash to share value works out to 1.20.

What Analysts Think About Harpoon Therapeutics, Inc.

While it’s never a good idea to blindly follow the opinions of analysts, it is a smart idea to use their analysis when validating your own when it comes to making an investment decision in the biotechnology space. Below you’ll find|Here are} the most recent moves that we’ve seen from analysts when it comes to HARP.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-05-19 Initiated Wedbush Outperform $23

What Are Big Money Players Doing With Harpoon Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in HARP, here’s what we’re seeing:

  • Institutional Investors – Currently, institutional investors own 35.20% of the company. Nonetheless, it is worth mentioning that institutional ownership has seen a move in the amount of 0 in the last quarter.
  • Investors On The Inside – As far as insiders go, members of the management team and others close to HARP currently own 0.50% of Harpoon Therapeutics, Inc.. Insider ownership of the company has moved 0 in the past quarter.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 23.18M shares of Harpoon Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, HARP has a float of 16.64M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to HARP, the short percent of the float is 0.27%.

What We’ve Seen In earnings results

What have ween seen from HARP in terms of financial results?Here’s the data:

  • Analyst Expectations – Currently, Wall Street analysts are expecting that the company will come up with earnings per diluted share in the amount of -1.49, with -0.73 being announced in the report for the current quarter. Although this isn’t based on earnings, because we’re chatting about Wall St. analysts, HARP is presently rated a 1.00 considering a scale that ranges from 1 to 5 on which 1 is the poorest Wall Street analyst grade and 5 is the best rating.
  • 5-Year Sales – In the last 5 years, Harpoon Therapeutics, Inc. has announced a change in sales volume that works out to be 0. EPS through the past 5 years have generated movement in the amount of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is often referred to as in the human world, Harpoon Therapeutics, Inc. has generated a change in earnings in the amount of 0. HARP has also experienced movement in regard to sales that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play a crucial part in my ability to learn. Sure, I can dig through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at something? If so, leave a comment below and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here